{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:09:00Z","timestamp":1781654940474,"version":"3.54.5"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02587","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T08:14:33Z","timestamp":1542183273000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of Age on NK Cell Compartment in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors"],"prefix":"10.3389","volume":"9","author":[{"given":"Paulo","family":"Rodrigues-Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"L\u00f3pez-Sejas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani Sofia","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Ruzi\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Couceiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corona","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Tarazona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Freitas-Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Solana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Santos-Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ni.3482","article-title":"NK cells and type 1 innate lymphoid cells: partners in host defense","volume":"17","author":"Spits","year":"2016","journal-title":"Nat Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1196\/annals.1392.001","article-title":"Telomere length in human natural killer cell subsets","volume":"1106","author":"Ouyang","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1023\/A:1015476114409","article-title":"Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals","volume":"22","author":"Tarazona","year":"2002","journal-title":"J Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.4049\/jimmunol.0901437","article-title":"Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment","volume":"183","author":"Gonzalez","year":"2009","journal-title":"J Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000365632","article-title":"Human natural killer cells: origin, receptors, function, and clinical applications","volume":"164","author":"Moretta","year":"2014","journal-title":"Int Arch Allergy Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","article-title":"Chronic myeloid leukaemia","volume":"370","author":"Hehlmann","year":"2007","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000140633","article-title":"BCR-ABL in chronic myelogenous leukemia\u2013how does it work?","volume":"119","author":"Goldman","year":"2008","journal-title":"Acta Haematol."},{"key":"B10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jnci\/90.11.850","article-title":"A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa","volume":"90","author":"Hasford","year":"1998","journal-title":"J Natl Cancer Inst."},{"key":"B12","first-page":"1400","article-title":"The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England","volume":"91","author":"Phekoo","year":"2006","journal-title":"Haematologica"},{"key":"B13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.beha.2009.07.007","article-title":"Epidemiology of chronic myeloid leukaemia (CML)","volume":"22","author":"Rohrbacher","year":"2009","journal-title":"Best Pract Res Clin Haematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/leu.2008.245","article-title":"Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph\/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany","volume":"23","author":"Rohrbacher","year":"2009","journal-title":"Leukemia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/00007611-198710000-00007","article-title":"Old age: a sign of poor prognosis in patients with chronic myelogenous leukemia","volume":"80","author":"Kantarjian","year":"1987","journal-title":"South Med J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1200\/JCO.1998.16.12.3782","article-title":"Determinants of prognosis in late chronic-phase chronic myelogenous leukemia","volume":"16","author":"Rodriguez","year":"1998","journal-title":"J Clin Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF03324904","article-title":"Immunosenescence and vaccine failure in the elderly","volume":"21","author":"Grubeck-Loebenstein","year":"2009","journal-title":"Aging Clin Exp Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1152\/physiol.00040.2007","article-title":"Aging of the immune system as a prognostic factor for human longevity","volume":"23","author":"Larbi","year":"2008","journal-title":"Physiology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ni.2588","article-title":"Understanding immunosenescence to improve responses to vaccines","volume":"14","author":"Goronzy","year":"2013","journal-title":"Nat Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.maturitas.2015.05.004","article-title":"Immunosenescence: implications for response to infection and vaccination in older people","volume":"82","author":"Pera","year":"2015","journal-title":"Maturitas"},{"key":"B21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fimmu.2013.00271","article-title":"Human T cell aging and the impact of persistent viral infections","volume":"4","author":"Fulop","year":"2013","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.coi.2014.04.002","article-title":"Shaping of NK cell subsets by aging","volume":"29","author":"Solana","year":"2014","journal-title":"Curr Opin Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.smim.2012.04.008","article-title":"Innate immunosenescence: Effect of aging on cells and receptors of the innate immune system in humans","volume":"24","author":"Solana","year":"2012","journal-title":"Semin Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3389\/fimmu.2016.00616","article-title":"Adaptive memory of human NK-like CD8+ T-cells to aging, and viral and tumor antigens","volume":"7","author":"Pita-Lopez","year":"2016","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-4933-6-11","article-title":"Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors","volume":"6","author":"Pita-Lopez","year":"2009","journal-title":"Immun Ageing"},{"key":"B26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/BOR.0000000000000011","article-title":"T-cell aging in rheumatoid arthritis","volume":"26","author":"Weyand","year":"2014","journal-title":"Curr Opin Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00262-015-1720-6","article-title":"Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?","volume":"65","author":"Sanchez-Correa","year":"2016","journal-title":"Cancer Immunol Immunother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fimmu.2016.00476","article-title":"Effect of CMV and aging on the differential expression of CD300a, CD161, T-bet, and eomes on NK cell subsets","volume":"7","author":"Lopez-Sejas","year":"2016","journal-title":"Front Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10522-015-9581-0","article-title":"Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age","volume":"16","author":"Campos","year":"2015","journal-title":"Biogerontology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.exger.2014.01.008","article-title":"Effect of age and CMV on NK cell subpopulations","volume":"54","author":"Campos","year":"2014","journal-title":"Exp Gerontol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000328005","article-title":"Immunosenescence of human natural killer cells","volume":"3","author":"Gayoso","year":"2011","journal-title":"J Innate Immun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0531-5565(98)00076-X","article-title":"NK phenotypic markers and IL2 response in NK cells from elderly people","volume":"34","author":"Borrego","year":"1999","journal-title":"Exp Gerontol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.mad.2005.01.004","article-title":"Reciprocal age related change in natural killer cell receptors for MHC class I","volume":"126","author":"Lutz","year":"2005","journal-title":"Mech Ageing Dev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.humimm.2011.01.009","article-title":"Age-related changes in natural killer cell receptors from childhood through old age","volume":"72","author":"Almeida-Oliveira","year":"2011","journal-title":"Hum Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1474-9726.2010.00584.x","article-title":"Human NK cells display major phenotypic and functional changes over the life span","volume":"9","author":"Le","year":"2010","journal-title":"Aging Cell"},{"key":"B36","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood.V88.6.2279.bloodjournal8862279","article-title":"CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis","volume":"88","author":"Pierson","year":"1996","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.4049\/jimmunol.168.2.643","article-title":"The BCR\/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients","volume":"168","author":"Nakajima","year":"2002","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood.V96.5.1961","article-title":"Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine","volume":"96","author":"Mellqvist","year":"2000","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.leu.2404080","article-title":"Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes","volume":"20","author":"Kiladjian","year":"2006","journal-title":"Leukemia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1182\/blood-2016-10-745992","article-title":"CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors","volume":"129","author":"Hughes","year":"2017","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fimmu.2017.00469","article-title":"Immune effector recovery in chronic myeloid leukemia and treatment-free remission","volume":"8","author":"Hughes","year":"2017","journal-title":"Front Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1182\/blood-2005-02-0479","article-title":"The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions","volume":"106","author":"Sconocchia","year":"2005","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-2567.2011.03521.x","article-title":"Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia","volume":"135","author":"Costello","year":"2012","journal-title":"Immunology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1182\/blood-2005-08-027979","article-title":"Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction","volume":"109","author":"Fauriat","year":"2007","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00262-011-1050-2","article-title":"Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands","volume":"60","author":"Sanchez-Correa","year":"2011","journal-title":"Cancer Immunol Immunother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/icb.2011.15","article-title":"Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients","volume":"90","author":"Sanchez-Correa","year":"2012","journal-title":"Immunol Cell Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"B48","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-term outcomes of imatinib treatment for chronic myeloid leukemia","volume":"376","author":"Hochhaus","year":"2017","journal-title":"N Engl J Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjh.12892","article-title":"How I determine if and when to recommend stopping tyrosine kinase inhibitor treatment for chronic myeloid leukaemia","volume":"166","author":"Ross","year":"2014","journal-title":"Br J Haematol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/leu.2016.115","article-title":"The concept of treatment-free remission in chronic myeloid leukemia","volume":"30","author":"Saussele","year":"2016","journal-title":"Leukemia"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1016\/S2352-3026(15)00196-9","article-title":"Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial","volume":"2","author":"Imagawa","year":"2015","journal-title":"Lancet Haematol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/leu.2011.239","article-title":"NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive mice","volume":"26","author":"Chen","year":"2012","journal-title":"Leukemia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.4049\/jimmunol.176.8.5108","article-title":"BCR\/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia","volume":"176","author":"Boissel","year":"2006","journal-title":"J Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/leu.2016.360","article-title":"Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia","volume":"31","author":"Ilander","year":"2017","journal-title":"Leukemia"},{"key":"B55","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/cas.13430","article-title":"Dasatinib cessation after deep molecular response exceeding 2 years, and NK cell transition during dasatinib consolidation","volume":"109","author":"Kumagai","year":"2017","journal-title":"Cancer Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"195956","DOI":"10.1155\/2012\/195956","article-title":"NK cells in healthy aging and age-associated diseases","volume":"2012","author":"Camous","year":"2012","journal-title":"J Biomed Biotechnol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.imlet.2014.06.015","article-title":"Proinflammatory status influences NK cells subsets in the elderly","volume":"162","author":"Campos","year":"2014","journal-title":"Immunol Lett."},{"key":"B58","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2567.2011.03446.x","article-title":"CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells","volume":"133","author":"Fu","year":"2011","journal-title":"Immunology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fimmu.2014.00087","article-title":"Human NK cells: from surface receptors to the therapy of leukemias and solid tumors","volume":"5","author":"Moretta","year":"2014","journal-title":"Front Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fimmu.2013.00362","article-title":"Modulation of NK cell function by genetically coupled C-type lectin-like receptor\/ligand pairs encoded in the human natural killer gene complex","volume":"4","author":"Bartel","year":"2013","journal-title":"Front Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fimmu.2015.00097","article-title":"NKG2D Ligands in tumor immunity: two sides of a coin","volume":"6","author":"Zhang","year":"2015","journal-title":"Front Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.0105-2896.2010.00893.x","article-title":"Effect of NKG2D ligand expression on host immune responses","volume":"235","author":"Champsaur","year":"2010","journal-title":"Immunol Rev."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02587\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T02:46:37Z","timestamp":1572662797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02587\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":63,"alternative-id":["10.3389\/fimmu.2018.02587"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02587","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,8]]},"article-number":"2587"}}